Financhill
Back

Agfa-Gevaert NV 10K Form

Sell
22

AFGVY
Agfa-Gevaert NV

Last Price:
1.42
Seasonality Move:
-1.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AFGVY News And Ratings

See the #1 stock for the next 7 days that we like better than AFGVY

AFGVY Financial Statistics

Sales & Book Value

Annual Sales: $1.25B
Cash Flow: $-8.35M
Price / Cash Flow: 0
Annual Sales: $5.17
Price / Book: 0.27

Profitability

EPS (TTM): -0.48010
Net Income (TTM): $-37.11M
Gross Margin: $387.57M
Return on Equity: -8.79%
Return on Assets: -2.47%

Agfa-Gevaert NV Earnings Forecast

Key Agfa-Gevaert NV Financial Ratios

  • The Gross Profit Margin over the past 22 years for AFGVY is 31.13%.
  • The Selling, General & Administrative Expenses for AFGVY have been equal to 26.96% of Gross Profit Margin.
  • The Research & Development expenses have been 6.35% of Revenue.
  • The Interest Expense is -37.25% of Operating Income.
  • The Net Earning history of AFGVY is -8.87% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

Agfa-Gevaert NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Technology
Sector: Health Care
Current Symbol: AFGVY
Website: agfa.com

Debt

Debt-to-Equity Ratio: 0.49
Current Ratio: 2.12
Quick Ratio: 1.09

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AFGVY Technical Analysis vs Fundamental Analysis

Sell
22
Agfa-Gevaert NV (AFGVY) is a Sell

Is Agfa-Gevaert NV a Buy or a Sell?

  • Agfa-Gevaert NV stock is rated a Sell
    The current Agfa-Gevaert NV [AFGVY] share price is $1.42. The Score for AFGVY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.